Market Overview

UPDATE: Stifel Nicolaus Raises PT to $41 on Patterson Companies on Positive Omnicam Impact

Related PDCO
10 Notable Stocks Trading Ex-Dividend Wednesday, October 12
15 Stocks Which Rallied Four Days, Then Sold Off Yesterday
Best Near-Term Price Gains Ahead For: Medical Equipment And Supplies Stocks (Seeking Alpha)

Stifel Nicolaus maintained Patterson Companies (NASDAQ: PDCO) with a Buy rating and raised the price target from $39.00 to $41.00.

Stifel Nicolaus commented, "Positive Omnicam diligence (5-10% of PDCO total sales) is a benefit for Patterson's dental equipment business. We bump our price target from $39 to $41 to reflect our favorable Omnicam replacement analysis and a function of expanding multiples within the peer group. However, with overall dental trends yet to meaningfully turn (dental consumables are 35% of Patterson's sales) we are more favorably disposed toward Sirona as the Omnicam product cycle has a more profound impact on numbers."

Patterson Companies closed at $36.81 on Tuesday.

Latest Ratings for PDCO

Oct 2016UBSInitiates Coverage onNeutral
Aug 2016BairdMaintainsNeutral
Aug 2016Bank of AmericaAssumesUnderperform

View More Analyst Ratings for PDCO
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings


Related Articles (PDCO)

View Comments and Join the Discussion!